Wandercraft Timeline

Events

• 2026-10-01 - Acquisition - Wandercraft completes acquisition of Ekso Bionics operating business - Atalante X and EksoNR together support patients at more than 700 rehabilitation centers worldwide. Wandercraft intends to keep supporting Atalante X, EksoNR, Eve and Indego Personal. Both boards unanimously approved the transaction, combining Wandercraft’s… - source: wandercraft.eu
• 2026-09-17 - Product Launch - Wandercraft commercially launches Eve exoskeleton in the U.S. - Eve is the first FDA-cleared personal exoskeleton without restrictions based on the neurological level of spinal cord injury, extending eligibility beyond previously cleared devices. National Seating & Mobility, Wandercraft's exclusive Complex Rehabilitation… - source: globenewswire.com
• 2026-09-04 - Market Signal - Wandercraft secures 12 Calvin-40 customers - Initial development targets handling boxes, parcels, tyres, panels and carts across industrial and logistics workflows. Finer picking and sorting functions were being developed and tested as extensions to larger-object handling. The production programme… - source: globenewswire.com
• 2026-08-11 - Regulatory - Wandercraft receives FDA clearance for Eve personal exoskeleton - Eve is intended for level indoor surfaces and level surfaces in immediately adjacent open-air areas such as patios and terraces, under the supervision of a specially trained companion. The clearance builds on Atalante X, Wandercraft's self-balancing… - source: wandercraft.eu
• 2026-07-27 - Regulatory - Ecuador authorises Wandercraft Atalante X for clinical rehabilitation - The authorised uses cover rehabilitation associated with spinal-cord injury, stroke-related hemiplegia and multiple sclerosis. Clínica de Lesiones Deportivas in Quito is the first announced Ecuador installation site. The clinic describes Atalante X as… - source: clinicadelesionesdeportivas.com
• 2026-03-12 - Deployment - Renault Group deploys 350 Wandercraft Calvin-40 humanoid robots - • Renault Group deployed 350 Wandercraft Calvin-40 humanoid robots in its factories over an 18-month period. • The robots performed physically demanding tasks, such as hauling tires, at the Douai factory's supply line. • This deployment followed a strategic… - source: autoexpress.co.uk
• 2026-03-12 - Deployment - Wandercraft Calvin-40 trials tyre handling at Renault Douai - Renault planned to add another 350 humanoids over the following 18 months. Calvin-40 was described as the second iteration, with AI training doubling its speed over six months. The programme followed Renault’s strategic partnership and minority investment in… - source: autoexpress.co.uk
• 2025-11-12 - Partnership - SAPA and Wandercraft agree Calvin-40 manufacturing partnership - The first implementation phase targets precise, repetitive movement of large and heavy parts. The companies will co-develop applications around high-throughput manufacturing workflows before scaling across tasks and locations. The agreement extends… - source: wandercraft.eu
• 2025-06-11 - Funding - Wandercraft secures US$75M funding and financing package - Major contributors included Renault Group, the PSIM fund managed by Bpifrance, Teampact Ventures and Quadrant Management. Other participants included LBO France, Mutuelles Impact managed by XAnge, Cemag Invest, Martagon Capital and AG2R La Mondiale. The… - source: globenewswire.com
• 2024-02-13 - Regulatory - Wandercraft's Atalante X receives second FDA clearance - • Wandercraft received FDA clearance for Atalante X for rehabilitation in individuals with spinal cord injuries at levels T5 to L5. • This follows the device's previous clearance for stroke rehabilitation in December 2022. • The clearance is supported by… - source: wandercraft.eu
• 2023-12-28 - Market Signal - Wandercraft receives EUR 25M EIB loan - The EIB loan supports development of Wandercraft's personal exoskeleton and access to Atalante X. The financing benefits from an InvestEU guarantee. The transaction is debt financing rather than a private-equity round. - source: eib.org
• 2022-01-19 - Funding - Wandercraft closes $45M Series C - Quadrant Management led the round, with existing investor Bpifrance also participating. Wandercraft allocated the capital to U.S. expansion and continued development of its self-balancing mobility systems. The later 2025 Wandercraft Series D announcement… - source: techcrunch.com